B-Cell Non-Hodgkins Lymphoma Treatment Market 2027 By Therapy, Route Of Administration, End User and Geography | The Insight Partners

B-Cell Non-Hodgkins Lymphoma Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy (Chemotherapy, Radiation therapy, Immunotherapy, Targeted therapy, Stem Cell therapy, Surgery); Route Of Administration (Oral, Parenteral, Others); End User (Hospitals, Retail Pharmacies, Oncology research centers, Others) and Geography

Report Code: TIPRE00015272 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

B- Cell Non -Hodgkin lymphoma is a type of Non- Hodgkin's lymphoma. Lymphomas are the cancer of white blood cells that commonly affects lymph nodes which makes lymph in body to fight infections. Basically NHL are of two types T cell lymphoma and a B cell lymphoma. Thus the B- cell NHL affects B lymphocytes and makes them abnormal. There are different subtypes of B-cell lymphoma such as DLBCL, Follicular lymphoma, Mantle cell lymphoma. Different treatment options available to treat these cancers such as, chemotherapy, radiation and others.

MARKET DYNAMICS

The key market drivers for B-Cell Non-Hodgkin's Lymphoma Treatment Market Includes, rising prevalence of B- Cell lymphoma across the globe, increasing novel therapies to treat Non-Hodgkin's lymphoma along with rising R&D expenditures by pharmaceutical/ biopharmaceutical companies to develop possible treatment options are the factors which will boost market during the forecast period. However, Side effects from the treatments, high cost of overall treatment are some factors which will hinder growth during the forecast period.

MARKET SCOPE

The "B-Cell Non-Hodgkin's Lymphoma Treatment Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of B-Cell Non-Hodgkin's Lymphoma Treatment Market with detailed market segmentation by, Therapy, Route of administration and end user. The B-Cell Non-Hodgkin's Lymphoma Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in B-Cell Non-Hodgkin's Lymphoma Treatment Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The B-Cell Non-Hodgkin's Lymphoma Treatment Market is segmented on the basis of, Therapy, route of administration and End User. On the basis of therapy the market is segmented as, radiation therapy, chemotherapy, stem cell therapy, surgery and others. On the basis of route of administration the market is segmented into, oral, parenteral and others. And on the basis of end user the market is segmented into hospitals, retail pharmacies, oncology research centers and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the B-Cell Non-Hodgkin's Lymphoma Treatment Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The B-Cell Non-Hodgkin's Lymphoma Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting B-Cell Non-Hodgkin's Lymphoma Treatment Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the B-Cell Non-Hodgkin's Lymphoma Treatment Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the B-Cell Non-Hodgkin's Lymphoma Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from B-Cell Non-Hodgkin's Lymphoma Treatment Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Aortic and Peripheral Vascular Interventional Therapy Product, market in the global market. Below mentioned is the list of few companies engaged in the B-Cell Non-Hodgkin's Lymphoma Treatment Market.

The report also includes the profiles of key players in B-Cell Non-Hodgkin's Lymphoma Treatment Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Hoffmann- La Roche Ltd
  •   Takeda Pharmaceutical Company Ltd
  •   AbbVie
  •   Novartis AG
  •   Abbott Laboratories
  •   Amgen Inc
  •   Johnson and Johnson
  •   Bristol- Myers Squibb Company
  •   Genentec,Inc
  •   Kite Pharma

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 B-Cell Non-Hodgkin's Lymphoma Treatment Market - By Therapy
1.3.2 B-Cell Non-Hodgkin's Lymphoma Treatment Market - By Route Of Administration
1.3.3 B-Cell Non-Hodgkin's Lymphoma Treatment Market - By End User
1.3.4 B-Cell Non-Hodgkin's Lymphoma Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. RADIATION THERAPY
7.4.1. Overview
7.4.2. Radiation therapy Market Forecast and Analysis
7.5. IMMUNOTHERAPY
7.5.1. Overview
7.5.2. Immunotherapy Market Forecast and Analysis
7.6. TARGETED THERAPY
7.6.1. Overview
7.6.2. Targeted therapy Market Forecast and Analysis
7.7. STEM CELL THERAPY
7.7.1. Overview
7.7.2. Stem Cell therapy Market Forecast and Analysis
7.8. SURGERY
7.8.1. Overview
7.8.2. Surgery Market Forecast and Analysis
8. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONCOLOGY RESEARCH CENTERS
9.5.1. Overview
9.5.2. Oncology research centers Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America B-Cell Non-Hodgkin's Lymphoma Treatment Market Overview
10.1.2 North America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis
10.1.3 North America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Therapy
10.1.4 North America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Route Of Administration
10.1.5 North America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By End User
10.1.6 North America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.1.6.1.1 United States B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.1.6.1.2 United States B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.1.6.1.3 United States B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.1.6.2 Canada B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.1.6.2.1 Canada B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.1.6.2.2 Canada B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.1.6.2.3 Canada B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.1.6.3 Mexico B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.1.6.3.1 Mexico B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.1.6.3.2 Mexico B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.1.6.3.3 Mexico B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.2. EUROPE
10.2.1 Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market Overview
10.2.2 Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis
10.2.3 Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Therapy
10.2.4 Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Route Of Administration
10.2.5 Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.2.6.1.1 Germany B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.2.6.1.2 Germany B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.2.6.1.3 Germany B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.2.6.2 France B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.2.6.2.1 France B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.2.6.2.2 France B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.2.6.2.3 France B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.2.6.3 Italy B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.2.6.3.1 Italy B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.2.6.3.2 Italy B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.2.6.3.3 Italy B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.2.6.4 Spain B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.2.6.4.1 Spain B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.2.6.4.2 Spain B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.2.6.4.3 Spain B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.2.6.5 United Kingdom B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.2.6.5.1 United Kingdom B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.2.6.5.2 United Kingdom B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.2.6.5.3 United Kingdom B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.2.6.6 Rest of Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.2.6.6.1 Rest of Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.2.6.6.2 Rest of Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.2.6.6.3 Rest of Europe B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market Overview
10.3.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Therapy
10.3.4 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Route Of Administration
10.3.5 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.3.6.1.1 Australia B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.3.6.1.2 Australia B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.3.6.1.3 Australia B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.3.6.2 China B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.3.6.2.1 China B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.3.6.2.2 China B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.3.6.2.3 China B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.3.6.3 India B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.3.6.3.1 India B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.3.6.3.2 India B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.3.6.3.3 India B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.3.6.4 Japan B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.3.6.4.1 Japan B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.3.6.4.2 Japan B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.3.6.4.3 Japan B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.3.6.5 South Korea B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.3.6.5.1 South Korea B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.3.6.5.2 South Korea B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.3.6.5.3 South Korea B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.3.6.6 Rest of Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.3.6.6.1 Rest of Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.3.6.6.2 Rest of Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.3.6.6.3 Rest of Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market Overview
10.4.2 Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Therapy
10.4.4 Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Route Of Administration
10.4.5 Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.4.6.1.1 South Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.4.6.1.2 South Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.4.6.1.3 South Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.4.6.2 Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.4.6.2.1 Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.4.6.2.2 Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.4.6.2.3 Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.4.6.3 U.A.E B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.4.6.3.1 U.A.E B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.4.6.3.2 U.A.E B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.4.6.3.3 U.A.E B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.4.6.4 Rest of Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.4.6.4.1 Rest of Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.4.6.4.2 Rest of Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.4.6.4.3 Rest of Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market Overview
10.5.2 South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis
10.5.3 South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Therapy
10.5.4 South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Route Of Administration
10.5.5 South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.5.6.1.1 Brazil B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.5.6.1.2 Brazil B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.5.6.1.3 Brazil B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.5.6.2 Argentina B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.5.6.2.1 Argentina B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.5.6.2.2 Argentina B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.5.6.2.3 Argentina B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
10.5.6.3 Rest of South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market
10.5.6.3.1 Rest of South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market by Therapy
10.5.6.3.2 Rest of South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market by Route Of Administration
10.5.6.3.3 Rest of South and Central America B-Cell Non-Hodgkin's Lymphoma Treatment Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. B-CELL NON-HODGKIN'S LYMPHOMA TREATMENT MARKET, KEY COMPANY PROFILES
12.1. TAKEDA PHARMACEUTICAL COMPANY LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. HOFFMANN LA- ROCHE LTD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABBVIE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AMGEN INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON AND JOHNSON
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BRISTOL -MYERS SQUIBB COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ABBOTT LABORATORIES
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GENENTECH INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. KITE PHARMA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Takeda Pharmaceutical Company Ltd
2. Hoffmann La- Roche Ltd
3. AbbVie
4. Novartis AG
5. Amgen Inc
6. Johnson and Johnson
7. Bristol -Myers Squibb Company
8. Abbott Laboratories
9. Genentech Inc
10. Kite Pharma
TIPRE00015272
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking